Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of ciprofloxacin and piperacillin/tazobactam in continuous renal replacement therapy
2010-021369-66Phase 4Completed
- Sponsor
- Apotheke der Universitätsmedizin Mainz
- Start
- Sep 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofloxacin and piperacillin + tazobactam in sepsis and acute kidney failure (AKF), sponsored by Apotheke der Universitätsmedizin Mainz. Primary endpoint: Collected blood-, dialysate- and urine-samples over 24 hours under continuous renal replacement therapy. Started Sep 2010; status: completed.
02
Drugs
ciprofloxacinpiperacillin + tazobactam
03
Conditions
sepsisacute kidney failure (AKF)
Beyond the preview
Go deeper on 2010-021369-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021369-66.